nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—ADORA1—coronary artery disease	0.363	1	CbGaD
Gabapentin—systemic lupus erythematosus—Acetylsalicylic acid—coronary artery disease	0.27	0.66	CpDpCtD
Gabapentin—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.14	0.34	CpDpCtD
Gabapentin—CACNA2D1—cardiac ventricle—coronary artery disease	0.000404	0.116	CbGeAlD
Gabapentin—BCAT1—heart—coronary artery disease	0.000402	0.116	CbGeAlD
Gabapentin—CACNA2D1—myocardium—coronary artery disease	0.00038	0.11	CbGeAlD
Gabapentin—CACNA2D2—heart—coronary artery disease	0.000368	0.106	CbGeAlD
Gabapentin—ADORA1—myocardium—coronary artery disease	0.000366	0.106	CbGeAlD
Gabapentin—CACNA2D2—cardiac atrium—coronary artery disease	0.000315	0.0909	CbGeAlD
Gabapentin—CACNA2D1—heart—coronary artery disease	0.000265	0.0765	CbGeAlD
Gabapentin—ADORA1—heart—coronary artery disease	0.000256	0.0738	CbGeAlD
Gabapentin—CACNA2D1—cardiovascular system—coronary artery disease	0.00025	0.0722	CbGeAlD
Gabapentin—ADORA1—cardiovascular system—coronary artery disease	0.000241	0.0696	CbGeAlD
Gabapentin—ADORA1—cardiac atrium—coronary artery disease	0.000219	0.0631	CbGeAlD
Gabapentin—ADORA1—Signaling Pathways—PF4—coronary artery disease	2.46e-05	0.000388	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MDK—coronary artery disease	2.46e-05	0.000388	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR3—coronary artery disease	2.45e-05	0.000387	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALDH2—coronary artery disease	2.44e-05	0.000385	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—coronary artery disease	2.44e-05	0.000385	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRB—coronary artery disease	2.43e-05	0.000383	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGT—coronary artery disease	2.43e-05	0.000383	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—coronary artery disease	2.4e-05	0.000378	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LIPC—coronary artery disease	2.38e-05	0.000375	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HBA1—coronary artery disease	2.38e-05	0.000375	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP2C19—coronary artery disease	2.38e-05	0.000375	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3C2A—coronary artery disease	2.38e-05	0.000375	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOC3—coronary artery disease	2.37e-05	0.000373	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LDLR—coronary artery disease	2.35e-05	0.000371	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—MAPK1—coronary artery disease	2.35e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RALBP1—coronary artery disease	2.35e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NPY5R—coronary artery disease	2.35e-05	0.00037	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2RL1—coronary artery disease	2.35e-05	0.00037	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—coronary artery disease	2.34e-05	0.000369	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTT1—coronary artery disease	2.32e-05	0.000366	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC9A1—coronary artery disease	2.32e-05	0.000366	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL3—coronary artery disease	2.31e-05	0.000364	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL2—coronary artery disease	2.31e-05	0.000364	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRA—coronary artery disease	2.3e-05	0.000362	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCLC—coronary artery disease	2.3e-05	0.000362	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CETP—coronary artery disease	2.3e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB1—coronary artery disease	2.29e-05	0.000361	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2R—coronary artery disease	2.28e-05	0.00036	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD36—coronary artery disease	2.28e-05	0.000359	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SDC1—coronary artery disease	2.27e-05	0.000358	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPP2CA—coronary artery disease	2.25e-05	0.000355	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—UTS2R—coronary artery disease	2.25e-05	0.000355	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FZD2—coronary artery disease	2.25e-05	0.000355	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—coronary artery disease	2.25e-05	0.000354	CbGpPWpGaD
Gabapentin—Malaise—Lisinopril—coronary artery disease	2.24e-05	0.00014	CcSEcCtD
Gabapentin—Oedema—Ramipril—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Anaphylactic shock—Ramipril—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Vertigo—Lisinopril—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Dry mouth—Timolol—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Constipation—Losartan—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Pain—Losartan—coronary artery disease	2.23e-05	0.000139	CcSEcCtD
Gabapentin—Syncope—Lisinopril—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Gabapentin—Vomiting—Eplerenone—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Gabapentin—Feeling abnormal—Furosemide—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Gabapentin—Leukopenia—Lisinopril—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Gabapentin—Nausea—Fenofibrate—coronary artery disease	2.22e-05	0.000138	CcSEcCtD
Gabapentin—Pruritus—Niacin—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Gabapentin—Asthenia—Pravastatin—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—EDNRB—coronary artery disease	2.21e-05	0.000348	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Furosemide—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Gabapentin—Rash—Eplerenone—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SFRP2—coronary artery disease	2.21e-05	0.000348	CbGpPWpGaD
Gabapentin—Urticaria—Perindopril—coronary artery disease	2.2e-05	0.000138	CcSEcCtD
Gabapentin—Hypersensitivity—Trandolapril—coronary artery disease	2.2e-05	0.000138	CcSEcCtD
Gabapentin—Dermatitis—Eplerenone—coronary artery disease	2.2e-05	0.000138	CcSEcCtD
Gabapentin—Diarrhoea—Valsartan—coronary artery disease	2.2e-05	0.000138	CcSEcCtD
Gabapentin—Confusional state—Timolol—coronary artery disease	2.2e-05	0.000137	CcSEcCtD
Gabapentin—Shock—Ramipril—coronary artery disease	2.2e-05	0.000137	CcSEcCtD
Gabapentin—Hypersensitivity—Enalapril—coronary artery disease	2.2e-05	0.000137	CcSEcCtD
Gabapentin—Abdominal pain—Perindopril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Body temperature increased—Perindopril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Palpitations—Lisinopril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Diarrhoea—Olmesartan—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Headache—Eplerenone—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Nervous system disorder—Ramipril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Gabapentin—Thrombocytopenia—Ramipril—coronary artery disease	2.19e-05	0.000136	CcSEcCtD
Gabapentin—Oedema—Timolol—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Anaphylactic shock—Timolol—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Pruritus—Pravastatin—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Loss of consciousness—Lisinopril—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Nausea—Clopidogrel—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Tachycardia—Ramipril—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Gabapentin—Skin disorder—Ramipril—coronary artery disease	2.17e-05	0.000135	CcSEcCtD
Gabapentin—Infection—Timolol—coronary artery disease	2.17e-05	0.000135	CcSEcCtD
Gabapentin—Vomiting—Simvastatin—coronary artery disease	2.17e-05	0.000135	CcSEcCtD
Gabapentin—Hypersensitivity—Telmisartan—coronary artery disease	2.17e-05	0.000135	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADORA3—coronary artery disease	2.16e-05	0.000341	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA4—coronary artery disease	2.16e-05	0.000341	CbGpPWpGaD
Gabapentin—Cough—Lisinopril—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Gabapentin—Nausea—Lovastatin—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL12—coronary artery disease	2.16e-05	0.00034	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—BDKRB2—coronary artery disease	2.16e-05	0.00034	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—coronary artery disease	2.16e-05	0.00034	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Ramipril—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Gabapentin—Rash—Simvastatin—coronary artery disease	2.15e-05	0.000134	CcSEcCtD
Gabapentin—Dermatitis—Simvastatin—coronary artery disease	2.15e-05	0.000134	CcSEcCtD
Gabapentin—Asthenia—Trandolapril—coronary artery disease	2.15e-05	0.000134	CcSEcCtD
Gabapentin—Shock—Timolol—coronary artery disease	2.15e-05	0.000134	CcSEcCtD
Gabapentin—Feeling abnormal—Losartan—coronary artery disease	2.15e-05	0.000134	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PSMA6—coronary artery disease	2.15e-05	0.000338	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PSMB5—coronary artery disease	2.15e-05	0.000338	CbGpPWpGaD
Gabapentin—Urticaria—Furosemide—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Gabapentin—Diarrhoea—Niacin—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Gabapentin—Nervous system disorder—Timolol—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Gabapentin—Asthenia—Enalapril—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Gabapentin—Headache—Simvastatin—coronary artery disease	2.14e-05	0.000133	CcSEcCtD
Gabapentin—Abdominal pain—Furosemide—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Gabapentin—Body temperature increased—Furosemide—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Gabapentin—Gastrointestinal pain—Losartan—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Gabapentin—Dizziness—Valsartan—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Gabapentin—Anorexia—Ramipril—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Gabapentin—Nausea—Ezetimibe—coronary artery disease	2.12e-05	0.000133	CcSEcCtD
Gabapentin—Skin disorder—Timolol—coronary artery disease	2.12e-05	0.000132	CcSEcCtD
Gabapentin—Dizziness—Olmesartan—coronary artery disease	2.12e-05	0.000132	CcSEcCtD
Gabapentin—Pruritus—Trandolapril—coronary artery disease	2.12e-05	0.000132	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PLCB1—coronary artery disease	2.11e-05	0.000333	CbGpPWpGaD
Gabapentin—Chest pain—Lisinopril—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Myalgia—Lisinopril—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Arthralgia—Lisinopril—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Hyperhidrosis—Timolol—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Asthenia—Telmisartan—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Pruritus—Enalapril—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Diarrhoea—Pravastatin—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Gabapentin—Anxiety—Lisinopril—coronary artery disease	2.1e-05	0.000131	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.1e-05	0.000131	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CTGF—coronary artery disease	2.1e-05	0.00033	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PGF—coronary artery disease	2.09e-05	0.00033	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPBP—coronary artery disease	2.09e-05	0.00033	CbGpPWpGaD
Gabapentin—Discomfort—Lisinopril—coronary artery disease	2.09e-05	0.00013	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—EDNRA—coronary artery disease	2.09e-05	0.000329	CbGpPWpGaD
Gabapentin—Hypotension—Ramipril—coronary artery disease	2.09e-05	0.00013	CcSEcCtD
Gabapentin—Anorexia—Timolol—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Gabapentin—Pruritus—Telmisartan—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—coronary artery disease	2.08e-05	0.000328	CbGpPWpGaD
Gabapentin—Nausea—Eplerenone—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ADRB1—coronary artery disease	2.08e-05	0.000327	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMGCR—coronary artery disease	2.08e-05	0.000327	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT2—coronary artery disease	2.08e-05	0.000327	CbGpPWpGaD
Gabapentin—Dizziness—Niacin—coronary artery disease	2.07e-05	0.000129	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—HTR7—coronary artery disease	2.07e-05	0.000326	CbGpPWpGaD
Gabapentin—Urticaria—Losartan—coronary artery disease	2.07e-05	0.000129	CcSEcCtD
Gabapentin—Dry mouth—Lisinopril—coronary artery disease	2.07e-05	0.000129	CcSEcCtD
Gabapentin—Abdominal pain—Losartan—coronary artery disease	2.06e-05	0.000128	CcSEcCtD
Gabapentin—Body temperature increased—Losartan—coronary artery disease	2.06e-05	0.000128	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ITGA2B—coronary artery disease	2.06e-05	0.000324	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DVL1—coronary artery disease	2.06e-05	0.000324	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGT—coronary artery disease	2.05e-05	0.000323	CbGpPWpGaD
Gabapentin—Asthenia—Captopril—coronary artery disease	2.05e-05	0.000128	CcSEcCtD
Gabapentin—Diarrhoea—Trandolapril—coronary artery disease	2.05e-05	0.000128	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—POMC—coronary artery disease	2.05e-05	0.000323	CbGpPWpGaD
Gabapentin—Vomiting—Valsartan—coronary artery disease	2.05e-05	0.000128	CcSEcCtD
Gabapentin—Confusional state—Lisinopril—coronary artery disease	2.04e-05	0.000127	CcSEcCtD
Gabapentin—Diarrhoea—Enalapril—coronary artery disease	2.04e-05	0.000127	CcSEcCtD
Gabapentin—Hypotension—Timolol—coronary artery disease	2.04e-05	0.000127	CcSEcCtD
Gabapentin—Dizziness—Pravastatin—coronary artery disease	2.04e-05	0.000127	CcSEcCtD
Gabapentin—Vomiting—Olmesartan—coronary artery disease	2.04e-05	0.000127	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Gabapentin—Rash—Valsartan—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Gabapentin—Dermatitis—Valsartan—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Gabapentin—Nausea—Simvastatin—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Oedema—Lisinopril—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Anaphylactic shock—Lisinopril—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Pruritus—Captopril—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Rash—Olmesartan—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Insomnia—Ramipril—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Dermatitis—Olmesartan—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Headache—Valsartan—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Gabapentin—Diarrhoea—Telmisartan—coronary artery disease	2.01e-05	0.000126	CcSEcCtD
Gabapentin—Infection—Lisinopril—coronary artery disease	2.01e-05	0.000126	CcSEcCtD
Gabapentin—BCAT1—Metabolism—APOE—coronary artery disease	2.01e-05	0.000317	CbGpPWpGaD
Gabapentin—Headache—Olmesartan—coronary artery disease	2.01e-05	0.000125	CcSEcCtD
Gabapentin—Paraesthesia—Ramipril—coronary artery disease	2e-05	0.000125	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—coronary artery disease	2e-05	0.000316	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—OPRD1—coronary artery disease	1.99e-05	0.000314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL4—coronary artery disease	1.99e-05	0.000314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHR—coronary artery disease	1.99e-05	0.000314	CbGpPWpGaD
Gabapentin—Shock—Lisinopril—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—Asthenia—Perindopril—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—Dyspnoea—Ramipril—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—Vomiting—Niacin—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Timolol—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—Hypersensitivity—Furosemide—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Gabapentin—BCAT1—Metabolism—APOA1—coronary artery disease	1.99e-05	0.000313	CbGpPWpGaD
Gabapentin—Somnolence—Ramipril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Gabapentin—Thrombocytopenia—Lisinopril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Gabapentin—Dizziness—Trandolapril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Gabapentin—Tachycardia—Lisinopril—coronary artery disease	1.98e-05	0.000123	CcSEcCtD
Gabapentin—Insomnia—Timolol—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Gabapentin—Rash—Niacin—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Gabapentin—Dermatitis—Niacin—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Gabapentin—Dizziness—Enalapril—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Gabapentin—Skin disorder—Lisinopril—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—KNG1—coronary artery disease	1.96e-05	0.00031	CbGpPWpGaD
Gabapentin—Dyspepsia—Ramipril—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Gabapentin—Pruritus—Perindopril—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—BDKRB2—coronary artery disease	1.96e-05	0.000309	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL12—coronary artery disease	1.96e-05	0.000309	CbGpPWpGaD
Gabapentin—Headache—Niacin—coronary artery disease	1.96e-05	0.000122	CcSEcCtD
Gabapentin—Paraesthesia—Timolol—coronary artery disease	1.96e-05	0.000122	CcSEcCtD
Gabapentin—Vomiting—Pravastatin—coronary artery disease	1.96e-05	0.000122	CcSEcCtD
Gabapentin—Hyperhidrosis—Lisinopril—coronary artery disease	1.96e-05	0.000122	CcSEcCtD
Gabapentin—Diarrhoea—Captopril—coronary artery disease	1.96e-05	0.000122	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR1—coronary artery disease	1.95e-05	0.000308	CbGpPWpGaD
Gabapentin—Dyspnoea—Timolol—coronary artery disease	1.95e-05	0.000121	CcSEcCtD
Gabapentin—Dizziness—Telmisartan—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Rash—Pravastatin—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Dermatitis—Pravastatin—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Decreased appetite—Ramipril—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Somnolence—Timolol—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Asthenia—Furosemide—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Gabapentin—Headache—Pravastatin—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Gabapentin—Anorexia—Lisinopril—coronary artery disease	1.93e-05	0.00012	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Ramipril—coronary artery disease	1.93e-05	0.00012	CcSEcCtD
Gabapentin—Fatigue—Ramipril—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Gabapentin—Dyspepsia—Timolol—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PLCB1—coronary artery disease	1.92e-05	0.000302	CbGpPWpGaD
Gabapentin—Hypersensitivity—Losartan—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MEF2A—coronary artery disease	1.91e-05	0.000301	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TLE4—coronary artery disease	1.91e-05	0.000301	CbGpPWpGaD
Gabapentin—Nausea—Valsartan—coronary artery disease	1.91e-05	0.000119	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PLCB1—coronary artery disease	1.91e-05	0.000301	CbGpPWpGaD
Gabapentin—Pruritus—Furosemide—coronary artery disease	1.91e-05	0.000119	CcSEcCtD
Gabapentin—Constipation—Ramipril—coronary artery disease	1.91e-05	0.000119	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL10—coronary artery disease	1.91e-05	0.000301	CbGpPWpGaD
Gabapentin—Nausea—Olmesartan—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Gabapentin—Vomiting—Trandolapril—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Gabapentin—Diarrhoea—Perindopril—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Gabapentin—Decreased appetite—Timolol—coronary artery disease	1.9e-05	0.000118	CcSEcCtD
Gabapentin—Vomiting—Enalapril—coronary artery disease	1.89e-05	0.000118	CcSEcCtD
Gabapentin—Hypotension—Lisinopril—coronary artery disease	1.89e-05	0.000118	CcSEcCtD
Gabapentin—Dizziness—Captopril—coronary artery disease	1.89e-05	0.000118	CcSEcCtD
Gabapentin—Rash—Trandolapril—coronary artery disease	1.89e-05	0.000118	CcSEcCtD
Gabapentin—Dermatitis—Trandolapril—coronary artery disease	1.88e-05	0.000118	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Timolol—coronary artery disease	1.88e-05	0.000118	CcSEcCtD
Gabapentin—Fatigue—Timolol—coronary artery disease	1.88e-05	0.000117	CcSEcCtD
Gabapentin—Rash—Enalapril—coronary artery disease	1.88e-05	0.000117	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—HTR7—coronary artery disease	1.88e-05	0.000296	CbGpPWpGaD
Gabapentin—Dermatitis—Enalapril—coronary artery disease	1.88e-05	0.000117	CcSEcCtD
Gabapentin—Headache—Trandolapril—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Gabapentin—Vomiting—Telmisartan—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Gabapentin—Asthenia—Losartan—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Gabapentin—Headache—Enalapril—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Gabapentin—Pain—Timolol—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—APOA2—coronary artery disease	1.86e-05	0.000294	CbGpPWpGaD
Gabapentin—Nausea—Niacin—coronary artery disease	1.86e-05	0.000116	CcSEcCtD
Gabapentin—Rash—Telmisartan—coronary artery disease	1.85e-05	0.000116	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB2—coronary artery disease	1.85e-05	0.000292	CbGpPWpGaD
Gabapentin—Dermatitis—Telmisartan—coronary artery disease	1.85e-05	0.000116	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—ABCA1—coronary artery disease	1.85e-05	0.000292	CbGpPWpGaD
Gabapentin—Diarrhoea—Furosemide—coronary artery disease	1.85e-05	0.000115	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Gabapentin—Pruritus—Losartan—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Gabapentin—Headache—Telmisartan—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—AVPR1A—coronary artery disease	1.84e-05	0.00029	CbGpPWpGaD
Gabapentin—Feeling abnormal—Ramipril—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Gabapentin—Dizziness—Perindopril—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Gabapentin—Insomnia—Lisinopril—coronary artery disease	1.83e-05	0.000114	CcSEcCtD
Gabapentin—Nausea—Pravastatin—coronary artery disease	1.83e-05	0.000114	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCE—coronary artery disease	1.83e-05	0.000288	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Ramipril—coronary artery disease	1.83e-05	0.000114	CcSEcCtD
Gabapentin—Paraesthesia—Lisinopril—coronary artery disease	1.82e-05	0.000113	CcSEcCtD
Gabapentin—Vomiting—Captopril—coronary artery disease	1.82e-05	0.000113	CcSEcCtD
Gabapentin—Dyspnoea—Lisinopril—coronary artery disease	1.8e-05	0.000113	CcSEcCtD
Gabapentin—Rash—Captopril—coronary artery disease	1.8e-05	0.000113	CcSEcCtD
Gabapentin—Dermatitis—Captopril—coronary artery disease	1.8e-05	0.000112	CcSEcCtD
Gabapentin—Somnolence—Lisinopril—coronary artery disease	1.8e-05	0.000112	CcSEcCtD
Gabapentin—Feeling abnormal—Timolol—coronary artery disease	1.8e-05	0.000112	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GGT1—coronary artery disease	1.79e-05	0.000283	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GOT1—coronary artery disease	1.79e-05	0.000283	CbGpPWpGaD
Gabapentin—Headache—Captopril—coronary artery disease	1.79e-05	0.000112	CcSEcCtD
Gabapentin—Gastrointestinal pain—Timolol—coronary artery disease	1.78e-05	0.000111	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—KNG1—coronary artery disease	1.78e-05	0.000281	CbGpPWpGaD
Gabapentin—Dizziness—Furosemide—coronary artery disease	1.78e-05	0.000111	CcSEcCtD
Gabapentin—Dyspepsia—Lisinopril—coronary artery disease	1.78e-05	0.000111	CcSEcCtD
Gabapentin—Diarrhoea—Losartan—coronary artery disease	1.78e-05	0.000111	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—UTS2—coronary artery disease	1.78e-05	0.00028	CbGpPWpGaD
Gabapentin—Nausea—Trandolapril—coronary artery disease	1.78e-05	0.000111	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AGTR1—coronary artery disease	1.77e-05	0.00028	CbGpPWpGaD
Gabapentin—Urticaria—Ramipril—coronary artery disease	1.77e-05	0.000111	CcSEcCtD
Gabapentin—Nausea—Enalapril—coronary artery disease	1.77e-05	0.000111	CcSEcCtD
Gabapentin—Vomiting—Perindopril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Gabapentin—Abdominal pain—Ramipril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Gabapentin—Body temperature increased—Ramipril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Gabapentin—Decreased appetite—Lisinopril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPARG—coronary artery disease	1.75e-05	0.000276	CbGpPWpGaD
Gabapentin—Rash—Perindopril—coronary artery disease	1.75e-05	0.000109	CcSEcCtD
Gabapentin—Dermatitis—Perindopril—coronary artery disease	1.75e-05	0.000109	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.75e-05	0.000109	CcSEcCtD
Gabapentin—Nausea—Telmisartan—coronary artery disease	1.75e-05	0.000109	CcSEcCtD
Gabapentin—Fatigue—Lisinopril—coronary artery disease	1.75e-05	0.000109	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NR4A1—coronary artery disease	1.74e-05	0.000274	CbGpPWpGaD
Gabapentin—Headache—Perindopril—coronary artery disease	1.74e-05	0.000109	CcSEcCtD
Gabapentin—Urticaria—Timolol—coronary artery disease	1.73e-05	0.000108	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CXCL10—coronary artery disease	1.73e-05	0.000273	CbGpPWpGaD
Gabapentin—Constipation—Lisinopril—coronary artery disease	1.73e-05	0.000108	CcSEcCtD
Gabapentin—Pain—Lisinopril—coronary artery disease	1.73e-05	0.000108	CcSEcCtD
Gabapentin—BCAT1—Metabolism—POMC—coronary artery disease	1.73e-05	0.000272	CbGpPWpGaD
Gabapentin—Body temperature increased—Timolol—coronary artery disease	1.72e-05	0.000108	CcSEcCtD
Gabapentin—Abdominal pain—Timolol—coronary artery disease	1.72e-05	0.000108	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PLCB3—coronary artery disease	1.72e-05	0.000271	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—P2RY12—coronary artery disease	1.72e-05	0.000271	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HDAC9—coronary artery disease	1.72e-05	0.000271	CbGpPWpGaD
Gabapentin—Dizziness—Losartan—coronary artery disease	1.72e-05	0.000107	CcSEcCtD
Gabapentin—Vomiting—Furosemide—coronary artery disease	1.72e-05	0.000107	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CX3CR1—coronary artery disease	1.7e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASR—coronary artery disease	1.7e-05	0.000269	CbGpPWpGaD
Gabapentin—Rash—Furosemide—coronary artery disease	1.7e-05	0.000106	CcSEcCtD
Gabapentin—Dermatitis—Furosemide—coronary artery disease	1.7e-05	0.000106	CcSEcCtD
Gabapentin—Nausea—Captopril—coronary artery disease	1.7e-05	0.000106	CcSEcCtD
Gabapentin—Headache—Furosemide—coronary artery disease	1.69e-05	0.000106	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ADRB2—coronary artery disease	1.68e-05	0.000265	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—P4HB—coronary artery disease	1.67e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BDKRB1—coronary artery disease	1.67e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNA12—coronary artery disease	1.67e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CX3CL1—coronary artery disease	1.67e-05	0.000263	CbGpPWpGaD
Gabapentin—Feeling abnormal—Lisinopril—coronary artery disease	1.67e-05	0.000104	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—coronary artery disease	1.66e-05	0.000262	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCE—coronary artery disease	1.66e-05	0.000262	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDN1—coronary artery disease	1.66e-05	0.000261	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Lisinopril—coronary artery disease	1.66e-05	0.000103	CcSEcCtD
Gabapentin—Vomiting—Losartan—coronary artery disease	1.66e-05	0.000103	CcSEcCtD
Gabapentin—Nausea—Perindopril—coronary artery disease	1.65e-05	0.000103	CcSEcCtD
Gabapentin—Hypersensitivity—Ramipril—coronary artery disease	1.64e-05	0.000103	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CCL5—coronary artery disease	1.64e-05	0.000259	CbGpPWpGaD
Gabapentin—Rash—Losartan—coronary artery disease	1.64e-05	0.000102	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPP3R1—coronary artery disease	1.64e-05	0.000259	CbGpPWpGaD
Gabapentin—Dermatitis—Losartan—coronary artery disease	1.64e-05	0.000102	CcSEcCtD
Gabapentin—Headache—Losartan—coronary artery disease	1.63e-05	0.000102	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADM—coronary artery disease	1.63e-05	0.000256	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CSF2—coronary artery disease	1.62e-05	0.000255	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—coronary artery disease	1.61e-05	0.000254	CbGpPWpGaD
Gabapentin—Urticaria—Lisinopril—coronary artery disease	1.61e-05	0.0001	CcSEcCtD
Gabapentin—Hypersensitivity—Timolol—coronary artery disease	1.61e-05	0.0001	CcSEcCtD
Gabapentin—Nausea—Furosemide—coronary artery disease	1.6e-05	0.0001	CcSEcCtD
Gabapentin—Asthenia—Ramipril—coronary artery disease	1.6e-05	0.0001	CcSEcCtD
Gabapentin—Abdominal pain—Lisinopril—coronary artery disease	1.6e-05	9.99e-05	CcSEcCtD
Gabapentin—Body temperature increased—Lisinopril—coronary artery disease	1.6e-05	9.99e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PPARGC1A—coronary artery disease	1.6e-05	0.000251	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—coronary artery disease	1.59e-05	0.00025	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CYBB—coronary artery disease	1.58e-05	0.00025	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDE4B—coronary artery disease	1.58e-05	0.00025	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—coronary artery disease	1.58e-05	0.00025	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MMP3—coronary artery disease	1.58e-05	0.000249	CbGpPWpGaD
Gabapentin—Pruritus—Ramipril—coronary artery disease	1.58e-05	9.86e-05	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ALB—coronary artery disease	1.57e-05	0.000248	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAT—coronary artery disease	1.57e-05	0.000247	CbGpPWpGaD
Gabapentin—Asthenia—Timolol—coronary artery disease	1.57e-05	9.78e-05	CcSEcCtD
Gabapentin—Nausea—Losartan—coronary artery disease	1.55e-05	9.65e-05	CcSEcCtD
Gabapentin—Pruritus—Timolol—coronary artery disease	1.54e-05	9.64e-05	CcSEcCtD
Gabapentin—Diarrhoea—Ramipril—coronary artery disease	1.53e-05	9.54e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—APOB—coronary artery disease	1.52e-05	0.00024	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—coronary artery disease	1.51e-05	0.000237	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDN1—coronary artery disease	1.5e-05	0.000237	CbGpPWpGaD
Gabapentin—Diarrhoea—Timolol—coronary artery disease	1.49e-05	9.32e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CCL5—coronary artery disease	1.49e-05	0.000235	CbGpPWpGaD
Gabapentin—Hypersensitivity—Lisinopril—coronary artery disease	1.49e-05	9.31e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCD—coronary artery disease	1.48e-05	0.000233	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—coronary artery disease	1.48e-05	0.000233	CbGpPWpGaD
Gabapentin—Dizziness—Ramipril—coronary artery disease	1.48e-05	9.22e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CSF2—coronary artery disease	1.47e-05	0.000232	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—coronary artery disease	1.45e-05	0.000229	CbGpPWpGaD
Gabapentin—Asthenia—Lisinopril—coronary artery disease	1.45e-05	9.07e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CCR3—coronary artery disease	1.45e-05	0.000228	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2A—coronary artery disease	1.45e-05	0.000228	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—C3—coronary artery disease	1.45e-05	0.000228	CbGpPWpGaD
Gabapentin—Dizziness—Timolol—coronary artery disease	1.44e-05	9.01e-05	CcSEcCtD
Gabapentin—Pruritus—Lisinopril—coronary artery disease	1.43e-05	8.94e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CRK—coronary artery disease	1.43e-05	0.000225	CbGpPWpGaD
Gabapentin—Vomiting—Ramipril—coronary artery disease	1.42e-05	8.86e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GPX1—coronary artery disease	1.42e-05	0.000223	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VWF—coronary artery disease	1.41e-05	0.000223	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ATP2A2—coronary artery disease	1.41e-05	0.000223	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SH2B3—coronary artery disease	1.41e-05	0.000223	CbGpPWpGaD
Gabapentin—Rash—Ramipril—coronary artery disease	1.41e-05	8.79e-05	CcSEcCtD
Gabapentin—Dermatitis—Ramipril—coronary artery disease	1.41e-05	8.78e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—APOC3—coronary artery disease	1.4e-05	0.000221	CbGpPWpGaD
Gabapentin—Headache—Ramipril—coronary artery disease	1.4e-05	8.73e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LDLR—coronary artery disease	1.4e-05	0.00022	CbGpPWpGaD
Gabapentin—Vomiting—Timolol—coronary artery disease	1.39e-05	8.66e-05	CcSEcCtD
Gabapentin—Diarrhoea—Lisinopril—coronary artery disease	1.39e-05	8.65e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CD36—coronary artery disease	1.38e-05	0.000218	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—coronary artery disease	1.38e-05	0.000217	CbGpPWpGaD
Gabapentin—Rash—Timolol—coronary artery disease	1.38e-05	8.59e-05	CcSEcCtD
Gabapentin—Dermatitis—Timolol—coronary artery disease	1.37e-05	8.58e-05	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—coronary artery disease	1.37e-05	0.000217	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP2CA—coronary artery disease	1.37e-05	0.000216	CbGpPWpGaD
Gabapentin—Headache—Timolol—coronary artery disease	1.37e-05	8.54e-05	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PPP2CA—coronary artery disease	1.36e-05	0.000215	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL3—coronary artery disease	1.36e-05	0.000215	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL2—coronary artery disease	1.36e-05	0.000215	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SDC1—coronary artery disease	1.35e-05	0.000212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2R—coronary artery disease	1.35e-05	0.000212	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCD—coronary artery disease	1.34e-05	0.000212	CbGpPWpGaD
Gabapentin—Dizziness—Lisinopril—coronary artery disease	1.34e-05	8.36e-05	CcSEcCtD
Gabapentin—Nausea—Ramipril—coronary artery disease	1.33e-05	8.28e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—FGB—coronary artery disease	1.32e-05	0.000208	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HTR2A—coronary artery disease	1.32e-05	0.000207	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—C3—coronary artery disease	1.31e-05	0.000207	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—coronary artery disease	1.31e-05	0.000206	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRB—coronary artery disease	1.3e-05	0.000206	CbGpPWpGaD
Gabapentin—Nausea—Timolol—coronary artery disease	1.3e-05	8.09e-05	CcSEcCtD
Gabapentin—Vomiting—Lisinopril—coronary artery disease	1.29e-05	8.04e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—THBS1—coronary artery disease	1.29e-05	0.000203	CbGpPWpGaD
Gabapentin—Rash—Lisinopril—coronary artery disease	1.28e-05	7.97e-05	CcSEcCtD
Gabapentin—Dermatitis—Lisinopril—coronary artery disease	1.28e-05	7.96e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PSMB5—coronary artery disease	1.27e-05	0.000201	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMA6—coronary artery disease	1.27e-05	0.000201	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—coronary artery disease	1.27e-05	0.0002	CbGpPWpGaD
Gabapentin—Headache—Lisinopril—coronary artery disease	1.27e-05	7.92e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AGT—coronary artery disease	1.25e-05	0.000197	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGT—coronary artery disease	1.24e-05	0.000196	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRA—coronary artery disease	1.23e-05	0.000194	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB1—coronary artery disease	1.23e-05	0.000193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CYBA—coronary artery disease	1.23e-05	0.000193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DUSP6—coronary artery disease	1.22e-05	0.000193	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—coronary artery disease	1.22e-05	0.000192	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA1—coronary artery disease	1.2e-05	0.00019	CbGpPWpGaD
Gabapentin—Nausea—Lisinopril—coronary artery disease	1.2e-05	7.51e-05	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PLAT—coronary artery disease	1.2e-05	0.000189	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—BDKRB2—coronary artery disease	1.16e-05	0.000183	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL12—coronary artery disease	1.16e-05	0.000183	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—POMC—coronary artery disease	1.16e-05	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—coronary artery disease	1.15e-05	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6ST—coronary artery disease	1.15e-05	0.000181	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JUNB—coronary artery disease	1.14e-05	0.000179	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLCB1—coronary artery disease	1.13e-05	0.000179	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR7—coronary artery disease	1.11e-05	0.000175	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—coronary artery disease	1.06e-05	0.000167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ITGAV—coronary artery disease	1.06e-05	0.000167	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KNG1—coronary artery disease	1.05e-05	0.000166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CREB1—coronary artery disease	1.05e-05	0.000166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—POMC—coronary artery disease	1.05e-05	0.000166	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR1—coronary artery disease	1.05e-05	0.000165	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—POMC—coronary artery disease	1.05e-05	0.000165	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—coronary artery disease	1.03e-05	0.000162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6R—coronary artery disease	1.02e-05	0.000162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL10—coronary artery disease	1.02e-05	0.000161	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLG—coronary artery disease	1.02e-05	0.000161	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRB2—coronary artery disease	9.94e-06	0.000157	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCE—coronary artery disease	9.81e-06	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—JAK2—coronary artery disease	9.81e-06	0.000155	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS1—coronary artery disease	9.79e-06	0.000154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—S100B—coronary artery disease	9.77e-06	0.000154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS3—coronary artery disease	9.67e-06	0.000152	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFBR2—coronary artery disease	9.55e-06	0.000151	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KITLG—coronary artery disease	9.55e-06	0.000151	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—coronary artery disease	9.54e-06	0.00015	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP3—coronary artery disease	9.34e-06	0.000147	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT5A—coronary artery disease	9.34e-06	0.000147	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—coronary artery disease	9.12e-06	0.000144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOB—coronary artery disease	9.03e-06	0.000142	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—coronary artery disease	8.95e-06	0.000141	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—JAK2—coronary artery disease	8.9e-06	0.00014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDN1—coronary artery disease	8.88e-06	0.00014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL5—coronary artery disease	8.81e-06	0.000139	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF1—coronary artery disease	8.68e-06	0.000137	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CSF2—coronary artery disease	8.68e-06	0.000137	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—coronary artery disease	8.62e-06	0.000136	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MEF2C—coronary artery disease	8.54e-06	0.000135	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RPS6KB1—coronary artery disease	8.54e-06	0.000135	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—coronary artery disease	8.47e-06	0.000134	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—coronary artery disease	8.34e-06	0.000132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ITGB3—coronary artery disease	8.32e-06	0.000131	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—coronary artery disease	8.13e-06	0.000128	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP2CA—coronary artery disease	8.09e-06	0.000127	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCD—coronary artery disease	7.94e-06	0.000125	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2A—coronary artery disease	7.77e-06	0.000122	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—C3—coronary artery disease	7.76e-06	0.000122	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—coronary artery disease	7.4e-06	0.000117	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—coronary artery disease	7.37e-06	0.000116	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—coronary artery disease	7.22e-06	0.000114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—coronary artery disease	7.22e-06	0.000114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—coronary artery disease	7.14e-06	0.000113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—coronary artery disease	7.08e-06	0.000112	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK14—coronary artery disease	7.03e-06	0.000111	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—coronary artery disease	6.92e-06	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—coronary artery disease	6.9e-06	0.000109	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—coronary artery disease	6.81e-06	0.000107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FN1—coronary artery disease	6.81e-06	0.000107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6ST—coronary artery disease	6.79e-06	0.000107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFKBIA—coronary artery disease	6.73e-06	0.000106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KIT—coronary artery disease	6.52e-06	0.000103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GSK3B—coronary artery disease	6.26e-06	9.86e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—POMC—coronary artery disease	6.21e-06	9.78e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CREB1—coronary artery disease	6.21e-06	9.78e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—coronary artery disease	6.07e-06	9.57e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6R—coronary artery disease	6.05e-06	9.54e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—coronary artery disease	5.97e-06	9.41e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK1—coronary artery disease	5.94e-06	9.37e-05	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.68e-06	8.95e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—coronary artery disease	5.67e-06	8.94e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—FGF2—coronary artery disease	5.49e-06	8.65e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—coronary artery disease	5.41e-06	8.53e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAK2—coronary artery disease	5.26e-06	8.29e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—coronary artery disease	5.16e-06	8.13e-05	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—coronary artery disease	5.13e-06	8.09e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—coronary artery disease	4.8e-06	7.57e-05	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—coronary artery disease	4.64e-06	7.31e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—coronary artery disease	4.6e-06	7.24e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—coronary artery disease	4.57e-06	7.2e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—coronary artery disease	4.47e-06	7.05e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—coronary artery disease	4.34e-06	6.84e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—coronary artery disease	4.21e-06	6.64e-05	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—coronary artery disease	4.19e-06	6.61e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—coronary artery disease	3.9e-06	6.15e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—coronary artery disease	3.58e-06	5.64e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK1—coronary artery disease	3.51e-06	5.53e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—coronary artery disease	3.05e-06	4.8e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—coronary artery disease	2.7e-06	4.25e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—coronary artery disease	2.49e-06	3.92e-05	CbGpPWpGaD
